230 related articles for article (PubMed ID: 24571485)
1. Economic evaluation of a hypothetical screening assay for alloimmunization risk among transfused patients with sickle cell disease.
Kacker S; Ness PM; Savage WJ; Frick KD; Shirey RS; King KE; Tobian AA
Transfusion; 2014 Aug; 54(8):2034-44. PubMed ID: 24571485
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of prospective red blood cell antigen matching to prevent alloimmunization among sickle cell patients.
Kacker S; Ness PM; Savage WJ; Frick KD; Shirey RS; King KE; Tobian AA
Transfusion; 2014 Jan; 54(1):86-97. PubMed ID: 23692415
[TBL] [Abstract][Full Text] [Related]
3. Medical and economic implications of strategies to prevent alloimmunization in sickle cell disease.
Gehrie EA; Ness PM; Bloch EM; Kacker S; Tobian AAR
Transfusion; 2017 Sep; 57(9):2267-2276. PubMed ID: 28653325
[TBL] [Abstract][Full Text] [Related]
4. Red blood cell alloimmunization in sickle cell disease: prevalence in 2010.
Miller ST; Kim HY; Weiner DL; Wager CG; Gallagher D; Styles LA; Dampier CD; Roseff SD;
Transfusion; 2013 Apr; 53(4):704-9. PubMed ID: 22804353
[TBL] [Abstract][Full Text] [Related]
5. Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review.
Fasano RM; Meyer EK; Branscomb J; White MS; Gibson RW; Eckman JR
Transfus Med Rev; 2019 Jan; 33(1):12-23. PubMed ID: 30122266
[TBL] [Abstract][Full Text] [Related]
6. Red cell alloantibodies in patients with haemoglobinopathies.
Hmida S; Mojaat N; Maamar M; Bejaoui M; Mediouni M; Boukef K
Nouv Rev Fr Hematol (1978); 1994 Oct; 36(5):363-6. PubMed ID: 7892131
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.
Aygun B; Padmanabhan S; Paley C; Chandrasekaran V
Transfusion; 2002 Jan; 42(1):37-43. PubMed ID: 11896310
[TBL] [Abstract][Full Text] [Related]
8. Red blood cell alloimmunization and minor red blood cell antigen phenotypes in transfused Ghanaian patients with sickle cell disease.
Boateng LA; Campbell AD; Davenport RD; Osei-Akoto A; Hugan S; Asamoah A; Schonewille H
Transfusion; 2019 Jun; 59(6):2016-2022. PubMed ID: 30758856
[TBL] [Abstract][Full Text] [Related]
9. Antigen-matched donor blood in the transfusion management of patients with sickle cell disease.
Tahhan HR; Holbrook CT; Braddy LR; Brewer LD; Christie JD
Transfusion; 1994 Jul; 34(7):562-9. PubMed ID: 8053036
[TBL] [Abstract][Full Text] [Related]
10. Antigen matching for transfusion support in Brazilian female patients with sickle cell disease to reduce RBC alloimmunization.
Muniz JG; Arnoni C; Medeiros R; Vendrame T; Cortez A; S Afonso J; Latini F; Castilho L; Girão M
Transfusion; 2021 Aug; 61(8):2458-2467. PubMed ID: 34121200
[TBL] [Abstract][Full Text] [Related]
11. Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications.
Castro O; Sandler SG; Houston-Yu P; Rana S
Transfusion; 2002 Jun; 42(6):684-90. PubMed ID: 12147019
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors.
Chou ST; Jackson T; Vege S; Smith-Whitley K; Friedman DF; Westhoff CM
Blood; 2013 Aug; 122(6):1062-71. PubMed ID: 23723452
[TBL] [Abstract][Full Text] [Related]
13. Alloimmunization in transfused patients with constitutional anemias in Norway.
Furuseth MT; Alme C; Garvik LJ; Hellebostad M; Bechensteen AG; Akkök ÇA
Transfus Apher Sci; 2021 Oct; 60(5):103257. PubMed ID: 34420880
[TBL] [Abstract][Full Text] [Related]
14. Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy.
Ambruso DR; Githens JH; Alcorn R; Dixon DJ; Brown LJ; Vaughn WM; Hays T
Transfusion; 1987; 27(1):94-8. PubMed ID: 3810834
[TBL] [Abstract][Full Text] [Related]
15. The value of transfusion of phenotyped blood units for thalassemia and sickle cell anemia patients at an academic center.
Hindawi S; Badawi M; Elfayoumi R; Elgemmezi T; Al Hassani A; Raml M; Alamoudi S; Gholam K
Transfusion; 2020 Feb; 60 Suppl 1():S15-S21. PubMed ID: 32134130
[TBL] [Abstract][Full Text] [Related]
16. Red blood cell alloimmunization in transfused patients with myelodysplastic syndrome or chronic myelomonocytic leukemia.
Sanz C; Nomdedeu M; Belkaid M; Martinez I; Nomdedeu B; Pereira A
Transfusion; 2013 Apr; 53(4):710-5. PubMed ID: 22845746
[TBL] [Abstract][Full Text] [Related]
17. Alloimmunization in sickle cell anemia in the era of extended red cell typing.
O'Suoji C; Liem RI; Mack AK; Kingsberry P; Ramsey G; Thompson AA
Pediatr Blood Cancer; 2013 Sep; 60(9):1487-91. PubMed ID: 23508932
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of Red Blood Cell Alloimmunization Among Pediatric Patients With Sickle Cell Disease in Saudi Arabia.
Al-Asmari B; Baothman A; Almohammadi M; Aljuaid M; Jastaniah W
J Pediatr Hematol Oncol; 2024 Jul; 46(5):e284-e289. PubMed ID: 38857199
[TBL] [Abstract][Full Text] [Related]
19. Effects of prophylactic red blood cell (RBC) transfusion with extended antigen matching on alloimmunization in patients with Sickle Cell Disease (SCD).
Leal I; Dos Santos TD; Gilli S; Castilho L
Transfus Apher Sci; 2023 Dec; 62(6):103813. PubMed ID: 37743224
[TBL] [Abstract][Full Text] [Related]
20. Red blood cell alloimmunization in sickle cell disease-prevalence and trends: a single-center cross-sectional study from United Kingdom.
Mijovic A; Perera IG; Thein SL
Transfusion; 2013 Dec; 53(12):3279-80. PubMed ID: 24320815
[No Abstract] [Full Text] [Related]
[Next] [New Search]
